Research / BLZE / Fundamental state Inspectable configuration
State dimensions Filing 0001462056-23-000190 General Corporate
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
6.90% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-21.30% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
18.86% · CORE · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
49.01% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
-56.59% · CORE · NOT_ENOUGH_HISTORY
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
40.36% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
19.86% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 20 states Self-history eligible
Sep 30, 2021 0/4 normalized Level 3 Dec 31, 2021 0/6 normalized Level 3 Mar 31, 2022 0/6 normalized Level 3 Jun 30, 2022 0/6 normalized Level 3 Sep 30, 2022 0/7 normalized Level 3 Dec 31, 2022 0/7 normalized Level 3 Mar 31, 2023 0/7 normalized Level 3 Jun 30, 2023 0/7 normalized Level 3 Sep 30, 2023 4/7 normalized Level 3 Dec 31, 2023 6/7 normalized Level 3 Mar 31, 2024 6/7 normalized Level 3 Jun 30, 2024 6/7 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 7/7 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/7 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 7/7 normalized Level 3 Mar 31, 2026 7/7 normalized Level 3 Jun 30, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Capex Intensity Decreased
Previous 12.92%
Current 6.90%
Delta -6.02% Cash Generation Increased
Previous -22.19%
Current -21.30%
Delta 0.89% Growth Decreased
Previous 20.03%
Current 18.86%
Delta -1.17% Margin Increased
Previous 46.89%
Current 49.01%
Delta 2.12% Profitability Increased
Previous -71.81%
Current -56.59%
Delta 15.23% R And D Intensity Decreased
Previous 45.02%
Current 40.36%
Delta -4.66% Sbc Intensity Decreased
Previous 24.91%
Current 19.86%
Delta -5.05% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.